A humanized anti-MSLN×4-1BB bispecific antibody exhibits potent antitumour activity through 4-1BB signaling activation and fc function without systemic toxicity

Abstract Background Agonistic monoclonal antibodies targeting 4-1BB/CD137 have shown preclinical promise, but their clinical development has been limited by severe liver toxicity or limited efficacy. Therefore, a safe and efficient immunostimulatory molecule is urgently needed for cancer immunothera...

書誌詳細
出版年:	Journal of Translational Medicine
主要な著者:	Da-yan Zhang, Zhi-hua Zhang, Wen-ting Liu, Wei-ming Zhou, Peng-fei Zhou, Juan-juan Wei, Xue-jing Dai, Xiao-li Zeng, Yu-qiong Zhou, Han-wang Li, Heng Zhang, Ao-lin Shen, Lian-sheng Cheng, Guo-dong Shen, Yi-fu He
フォーマット:	論文
言語:	英語
出版事項:	BMC 2025-01-01
主題:	4-1BB/CD137 MSLN Bispecific antibody Cancer immunotherapy Antitumour immunity
オンライン･アクセス:	https://doi.org/10.1186/s12967-025-06107-z

類似資料

Accelerating Cancer Immunotherapy Through 4-1BB Activation
著者:: Todd eBartkowiak, 等
出版事項: (2015-06-01)

An Fc-muted bispecific antibody targeting PD-L1 and 4-1BB induces antitumor immune activity in colorectal cancer without systemic toxicity
著者:: Lian-sheng Cheng, 等
出版事項: (2023-05-01)

4-1BB Antibodies in Oncology Clinical Trials: A Review
著者:: Robin Schwartz, 等
出版事項: (2025-03-01)

4-1BB: A promising target for cancer immunotherapy
著者:: Alyssa Min Jung Kim, 等
出版事項: (2022-09-01)

1192 A novel MSLN×4–1BB bispecific antibody for solid tumor
著者:: Guodong Shen, 等
出版事項: (2023-11-01)

CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs
著者:: Juan M. Zapata, 等
出版事項: (2018-11-01)

The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy
著者:: Christina Claus, 等
出版事項: (2023-12-01)

Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)
著者:: Arantza Azpilikueta, 等
出版事項: (2018-01-01)

Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications
著者:: Shahram Salek-Ardakani, 等
出版事項: (2023-08-01)

Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes
著者:: Elisa Claeys, 等
出版事項: (2021-04-01)

Carcinoembryonic Antigen (CEA)-Specific 4-1BB-Costimulation Induced by CEA-Targeted 4-1BB-Agonistic Trimerbodies
著者:: Kasper Mikkelsen, 等
出版事項: (2019-07-01)

OCULAR INJURIES CAUSED BY BB GUN
著者:: M.S. Farahvash
出版事項: (1999-09-01)

MSLN induced EMT, cancer stem cell traits and chemotherapy resistance of pancreatic cancer cells
著者:: Jili Hu, 等
出版事項: (2024-04-01)

Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism
著者:: Iñaki Eguren-Santamaría, 等
出版事項: (2024-12-01)

Targeting CD137 (4-1BB) towards improved safety and efficacy for cancer immunotherapy
著者:: Guizhong Liu, 等
出版事項: (2023-06-01)

Advances in the use of nanomicelles to enhance the efficacy of antitumour substances (review)
著者:: E. V. Sanarova, 等
出版事項: (2025-06-01)

Isoliquiritigen Enhances the Antitumour Activity and Decreases the Genotoxic Effect of Cyclophosphamide
著者:: Qiusheng Zheng, 等
出版事項: (2013-07-01)

Insights into the role of MSLN-positive circulating tumor cell as an auxiliary diagnostic biomarker in epithelial ovarian cancer
著者:: Hang Xu, 等
出版事項: (2025-07-01)

The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses
著者:: Isabel eBarao
出版事項: (2013-01-01)

Anti-CD166/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma
著者:: Yitian Wang, 等
出版事項: (2019-04-01)

Antibacterial and anti-biofilm activities of Disaspidin BB against Staphylococcus epidermidis
著者:: Shihua Lan, 等
出版事項: (2023-01-01)

Serum Biopterin as a Marker of Immune Activation in the Spontaneously Diabetic BB Rat
著者:: Galloway Tamara, 等
出版事項: (1998-11-01)

Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)
著者:: Kübra Kaban, 等
出版事項: (2021-11-01)

Selenium nanoparticles enhance the anti-tumor immune responses of anti-4-1BB antibody and alleviate the adverse effects on mice
著者:: Lei zhang, 等
出版事項: (2024-09-01)

Targeting 4–1BB with fucoidan from Fucus vesiculosus: A strategy to activate macrophages and remodel the immunosuppressive microenvironment for pancreatic cancer therapy
著者:: Yi Wang, 等
出版事項: (2025-03-01)

<i>N</i>-Glycosylation Facilitates 4-1BB Membrane Localization by Avoiding Its Multimerization
著者:: Ruoxuan Sun, 等
出版事項: (2022-01-01)

Semi device independence of the BB84 protocol
著者:: Erik Woodhead
出版事項: (2016-01-01)

CD28 is superior to 4-1BB costimulation in generating CAR-NK cells for tumor immunotherapy
著者:: Pengchao Zhang, 等
出版事項: (2025-03-01)

Bases selection with pseudo-random functions in BB84 scheme
著者:: Emir Dervisevic, 等
出版事項: (2024-01-01)

Aptamer-gelatin composite material for prolonging PDGF-BB release
著者:: Boonchoy Soontornworajit, 等
出版事項: (2020-02-01)

Flavaspidic acid BB combined with mupirocin improves its anti-bacterial and anti-biofilm activities against Staphylococcus epidermidis
著者:: Zhiling Cai, 等
出版事項: (2022-07-01)

A Bispecific Antibody-Based Approach for Targeting Mesothelin in Triple Negative Breast Cancer
著者:: Joanie Del Bano, 等
出版事項: (2019-07-01)

A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity
著者:: Po-Lin Huang, 等
出版事項: (2023-05-01)

4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells
著者:: Qiang Dai, 等
出版事項: (2020-11-01)

Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent
著者:: Diogo Gomes-Silva, 等
出版事項: (2017-10-01)

Divergent synthesis and antitumour activity of novel conformationally constrained (−)-muricatacin analogues
著者:: Stanisavljević Slađana M., 等
出版事項: (2023-01-01)

Forward genetic screen using a gene-breaking trap approach identifies a novel role of grin2bb-associated RNA transcript (grin2bbART) in zebrafish heart function
著者:: Ramcharan Singh Angom, 等
出版事項: (2024-03-01)

PDGF-BB-derived supramolecular hydrogel for promoting skin wound healing
著者:: Ke Jian, 等
出版事項: (2022-04-01)

Antibacterial activity and antibacterial mechanism of flavaspidic acid BB against Staphylococcus haemelyticus
著者:: Jiaxin Liu, 等
出版事項: (2023-09-01)

Performance Evaluation of BB-QZSI-Based DSTATCOMUnder Dynamic Load Condition
著者:: Mangaraj Mrutyunjaya, 等
出版事項: (2022-01-01)